The Princess Alexandra Hospital NHS Trust serves a population of 258,000 and provides healthcare services to the communities of Harlow and the surrounding areas.

During the past decade, Princess Alexandra Hospital; Oncology Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Princess Alexandra Hospital; Oncology Department" are "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Princess Alexandra Hospital; Oncology Department" in a lesser frequency.

Most popular intervention types in "Princess Alexandra Hospital; Oncology Department" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Fulvestrant" (1 trials), "Fulvestrant or an Aromatase Inhibitor (Physician Choice)" (1 trials), "Giredestrant" (1 trials), "Herceptin" (1 trials) and "Inavolisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Princess Alexandra Hospital; Oncology Department" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Princess Alexandra Hospital; Oncology Department". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Princess Alexandra Hospital; Oncology Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Princess Alexandra Hospital; Oncology Department, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".